More about

Renal Failure

News
September 24, 2020
4 min read
Save

DAPA-CKD: Dapagliflozin prolongs survival in CKD with, without type 2 diabetes

Treatment with dapagliflozin significantly reduced renal failure, cardiovascular death or hospitalization for heart failure, and prolonged survival among adults with chronic kidney disease with and without type 2 diabetes, study data show.

News
September 24, 2020
3 min read
Save

Sex, race identified as potential factors for 1-year survival in HFpEF

Men hospitalized with HF with preserved ejection fraction experienced elevated risk for 1-year all-cause mortality compared with women, researchers reported.

News
July 13, 2020
2 min read
Save

Early type 2 diabetes diagnosis drives long-term kidney disease risk

Adults diagnosed with type 2 diabetes before age 30 years are more likely to develop renal failure over time compared with those with a shorter diabetes duration, according to a database analysis published in Diabetes Care.

News
June 01, 2020
12 min watch
Save

VIDEO: Ophthalmologists discuss deployment to front lines in coronavirus pandemic

Leela V. Raju, MD, clinical associate professor at NYU Langone, and Sonya Dhar, MD, clinical instructor of ophthalmology at NYU Langone, discuss being deployed to help care for patients with COVID-19.

News
May 21, 2020
3 min read
Save

No difference by hospital volume in events after TAVR for bicuspid aortic valves

Low- and high-volume hospitals that performed transcatheter aortic valve replacement for bicuspid aortic valves had similar rates of in-hospital and 30-day outcomes, researchers reported.

News
May 05, 2020
2 min read
Save

Tacrolimus safe, effective in lupus nephritis through 5 years

Tacrolimus maintenance over 5 years is well-tolerated and effective among patients with lupus nephritis, according to data published in The Journal of Rheumatology.

News
March 17, 2020
6 min read
Save

PARAGON-HF: Lowest risk in HFpEF observed with 120-129 mm Hg systolic BP

Patients with HF with preserved ejection fraction who had a baseline and mean achieved systolic BP between 120 mm Hg and 129 mm Hg had the lowest risk for CV and other outcomes compared with higher systolic BP, according to new analysis of the PARAGON-HF trial.

News
March 12, 2020
2 min read
Save

Inappropriate anticoagulant dosing common in older patients with AF

An analysis of the ongoing SAGE-AF trial revealed that approximately 23% of geriatric patients with atrial fibrillation and prescribed a direct oral anticoagulant received inappropriate dosing.

News
March 06, 2020
2 min read
Save

10% of patients readmitted more than once within 6 months after PCI

Nearly 1 in 10 patients are readmitted to the hospital multiple times within 180 days post-PCI and nearly one-quarter of those with multiple readmissions return to the hospital for the same cause each time, according to research published in Catheterization and Cardiovascular Interventions.

News
March 02, 2020
2 min read
Save

Risk for sudden arrhythmic death with QT-prolonging medications may be overestimated

QT-prolonging medications are associated with an increased risk for sudden cardiac death, but research published in JAMA Internal Medicine showed that this risk was specifically linked to nonarrhythmic causes.

View more